TrialJournal of neurology2024

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study.

Vineet Punia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.